P2Y2 expressing cells, mostly myeloid cells, are increased in the intestinal tract of allo-HSCT recipients with GVHD, with the presence of P2Y2-expressing cells associated with increased intestinal GVHD severity [125]. Here, P2RY2 is linked to graft versus host disease.